Health Care · Services-Specialty Outpatient Facilities, NEC

ACHC Acadia Healthcare Company Inc SEC Filings & Insider Trading Activity 2026

company
CIK 152069783 filings

ACHC at a glance

Acadia Healthcare Company Inc (ACHC, SEC CIK 1520697) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and Form 4 insider filings as recently as July 27, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Acadia Healthcare Company Inc (ACHC) reported revenue of $3.3 billion (up 5.0% from FY2024) and a net loss of $1.1 billion. Diluted EPS was -$12.16.
  • As of September 30, 2026, 32 institutional investment managers tracked by SignalX reported holding Acadia Healthcare Company Inc (ACHC) shares worth $1.4 billion in 13F-HR filings.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$3.3B
+5.0% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
32 funds
$1.4B · −1 vs prior quarter
Latest 8-K
Nov 4, 2026
Item 2.02 · Item 7.01

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Risk Factors

  • No material changes to 2025 Form 10-K risk factors disclosed
  • Carried-forward risk: additional unknown risks could materially adversely affect business, financial condition, results, or cash flows

Management Discussion & Analysis

  • Q3 revenue $895.3M, up 5.1% YoY from $851.6M, driven by same-facility revenue growth of 5.2%
  • Net income $38.7M, 4.3% margin vs 4.5% YoY; effective tax rate 31.6% vs 4.2%
  • Same-facility admissions grew 6.6%, while average length of stay declined 5.1%
  • Operating cash flow $321.5M vs $218.2M; capital expenditures $165.9M, including $94.8M expansion spending
  • Cash $163.3M vs $133.2M; Medicaid reforms may pressure reimbursement, though management expects exemptions to limit near-term impact

AI summary of the ACHC 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 4, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Q3 2026 operating and financial results announced for the quarter ended September 30, 2026
  • Full results and management commentary available in Exhibit 99.1 press release

Item 7.01: Regulation FD Disclosure

  • Third-quarter 2026 results conference call scheduled for November 5, 2026 at 9:00 a.m. Eastern Time
  • Investor slides in Exhibit 99.2 may contain operating and financial details not included in this section

Item EX-99.1: Item EX-99.1

  • Q3 revenue $895.3M, up 5.1%, with same-facility revenue up 5.2% on 1.1% higher patient days and 4.0% pricing growth
  • Adjusted EBITDA $176.4M, up 2%, but adjusted EPS fell 17% to $0.60 as reported net income declined 5% to $34.5M
Filed Sep 25, 2026Full analysis →

Item 8.01: Other Events

  • Court preliminary approval of settlement resolving stockholder derivative claims against individual defendants
  • Settlement covers four derivative actions tied to securities litigation settled in November 2025
Filed Jul 28, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Press release announces Acadia Healthcare’s second-quarter fiscal 2026 operating and financial results
  • Reporting period ended June 30, 2026

Item 7.01: Regulation FD Disclosure

  • Conference call scheduled for Q2 2026 results on July 29, 2026 at 9:00 a.m. Eastern Time
  • Exhibit 99.2 slides may contain supplemental operating and financial information for investors

Item EX-99.1: Item EX-99.1

  • Q2 revenue $865.8M, approximately flat, but normalized growth 2.8% after supplemental-payment timing
  • Reported EPS $0.12 vs $0.33, while Adjusted EPS $0.38 vs $0.83, reflecting significant earnings pressure

AI summaries of ACHC 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ACHC

Don't miss the next ACHC filing

  • Alerts as it files. A push when ACHC files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ACHC, by share count.
  • Ask anything. An AI agent that reads every ACHC filing and answers with sources.

ACHC alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Farley BrianFJul 26, 2026$34.51
Farley BrianFJun 26, 2026$26.24
Farley BrianFJun 26, 2026$26.24
Fucci MichaelAMay 6, 2026-
WAUD REEVE BAMay 6, 2026-
WAUD REEVE BAMay 6, 2026-
KELLY RALPH DAVIDAMay 6, 2026-
Cancelmi Daniel JAMay 6, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue$2.9B$3.2B$3.3B
Net Income-$21.7M$255.6M-$1.1B
Net Margin-0.7%8.1%-33.3%
Balance Sheet
Total Assets$5.4B$6.0B$5.5B
Equity$2.8B$3.1B$1.9B
ROE-0.8%8.3%-56.6%
Per Share
EPS-$2.78$-12.16
Cash Flow
Operating CF$462.3M$129.7M$131.9M
CapEx$424.1M$690.4M$571.8M

Source: XBRL data in Acadia Healthcare Company Inc (ACHC)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate ACHC share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ACHC shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202632$1.44B
Q2 202633$1.68B
Q1 202632$1.21B
Q4 202530$704.8M
Q3 202529$1.08B
Q2 202530$938.7M
Q1 202527$926.9M
Q4 202424$1.13B
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 237 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ACHC filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 4, 2026Analysis
8-KNov 4, 2026Analysis-
8-KSep 25, 2026Analysis-
8-KJul 28, 2026Analysis-
10-QJul 28, 2026-
4Jul 27, 2026--
4Jun 26, 2026--
8-KMay 18, 2026-
4May 8, 2026-
4May 8, 2026-
4May 8, 2026-
4May 8, 2026-
4May 8, 2026-
4May 8, 2026-
4May 8, 2026-
4May 8, 2026-
4May 8, 2026-
4May 6, 2026-
8-KMay 6, 2026-
10-QApr 30, 2026-
4Apr 30, 2026--
8-KApr 29, 2026--
8-KApr 23, 2026--
4Apr 13, 2026--
4Apr 13, 2026--

Related Health Care companies

All Health Care →

ACHC SEC filings: frequently asked questions

Which institutions hold ACHC stock?

As of September 30, 2026, the largest Acadia Healthcare Company Inc (ACHC) holders among the 13F filers tracked by SignalX were BlackRock ($407.8 million), Vanguard Portfolio Management LLC ($154.3 million), Dimensional Fund Advisors ($129.2 million), Vanguard Capital Management LLC ($115.9 million), State Street Corp ($105.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ACHC's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Acadia Healthcare Company Inc (ACHC) reported revenue of $3.3 billion (up 5.0% from FY2024) and a net loss of $1.1 billion. Diluted EPS was -$12.16. The figures come from the XBRL data in the 10-K.

What did ACHC report in its latest 8-K?

Acadia Healthcare Company Inc (ACHC) filed an 8-K on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure). Q3 2026 operating and financial results announced for the quarter ended September 30, 2026.

What are the latest ACHC SEC filings?

Acadia Healthcare Company Inc (ACHC) filed its latest 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 4, 2026, an 8-K current report on November 4, 2026 and a Form 4 insider filing on July 27, 2026.

What is ACHC's SEC CIK number?

Acadia Healthcare Company Inc (ACHC)'s SEC Central Index Key (CIK) is 1520697. EDGAR lists every ACHC filing under that number.

Ask anything about ACHC

The research agent reads ACHC's filings, financials, insider trades and 13F holders, then answers with sources.